Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic bone marrow mesenchymal stem cells

bone marrow-derived mesenchymal stem cells
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Allogeneic bone marrow mesenchymal stem cells, covering 2011-04-11 to 2017-01-25. Get the full timeline:

Most recent: Clinical Trial Update: Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD [Phase 1, Phase 2]

See pricing